Find information on thousands of medical conditions and prescription drugs.

Neulasta

Granulocyte Colony-Stimulating Factor (G-CSF) is a glycoprotein, growth factor or cytokine produced by a number of different tissues to stimulate the bone marrow to produce granulocytes. It also stimulates the survival, proliferation, differentiation, and function of neutrophil granulocyte progenitor cells and mature neutrophils. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
Nabilone
Nadolol
Nafarelin
Nafcillin
Nalbuphine
Nalidixic acid
Nallpen
Naloxone
Naltrexone
Nandrolone
Naphazoline
Naprelan
Naprosyn
Naproxen
Naratriptan
Narcan
Nardil
Naropin
Nasacort
Nasalcrom
Nascobal
Natamycin
Navane
Navelbine
Nebcin
Nebracetam
Nefazodone
Nefiracetam
Nelfinavir
Nembutal
Neoarsphenamine
Neomycin
Neoral
Neosporin
Neulasta
Neupogen
Neurontin
Nevirapine
Nexium
Nialamide
Niaspan
Niclosamide
Nicoderm
Nicorette
Nicotinamide
Nicotine
Nicotinic acid
Nicotrol
Nifedipine
Nifehexal
Nikethamide
Nilstat
Nilutamide
Nimesulide
Nimodipine
Nimotop
Nitrazepam
Nitrofurantoin
Nix
Nizatidine
Nizoral
Nocodazole
Nolvadex
Nomifensine
Norco
Nordazepam
Nordette
Norepinephrine
Norethin
Norfloxacin
Norgestimate
Norgestrel
Norinyl
Noritate
Normodyne
Norplant
Norpramin
Nortriptyline
Norvasc
Norvir
Noscapine
Novafed
Novobiocin
Novocain
Novrad
Nuprin
Nysert
Nystaform
Nystatin
Nystex
Nystop
O
P
Q
R
S
T
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]



Pharmaceutical: top 50 packages
PHARMACEUTICAL
FDA Expands Neulasta® Label; New Label Extends First-Cycle Protection From Infection To Cancer Patients Receiving Moderately Myelosuppressive Chemotherapy
THOUSAND OAKS, Calif. -- Amgen (Nasdaq: AMGN), the world's largest biotechnology company, today announced that the U.S. Food and Drug Administration ...
Large Community-Based Clinical Trial in Older Cancer Patients Suggests Benefits of Neulasta in First and Subsequent Cycles Of Chemotherapy
ORLANDO, Fla. -- Amgen Inc., (NASDAQ:AMGN) the world's largest biotechnology company, today announced that an initial report from a study of 701 older ...
AMGEN INC.: Improving Your Life
Amgen's revenue and earnings have been growing at a high rate, consistently, for a long time. With such stocks, there is always the risk of a sharp decline ...
Phase 3 Study Published in The Journal of Clinical Oncology Shows First-Cycle Administration of Neulasta Significantly Lowers Incidence of Neutropenia
THOUSAND OAKS, Calif. -- Amgen Inc. (Nasdaq:AMGN), the world's largest biotechnology company, today announced that data from the largest randomized placebo-controlled study to date for Neulasta(R)
Biotechnology drugs face high hurdles in suppliers' bid for broader distribution
NEW YORK -- Biotechnology is the fastest-growing segment of the pharmaceutical industry, but it almost certainly never will capture more than a small ...
Phase 3 Study Shows Majority of Neutropenia with Related Fever and Hospitalization Occurs in First Treatment Cycle for Breast Cancer Patients Not Receiving
THOUSAND OAKS, Calif. -- The Largest Randomized Placebo-Controlled Study to Date for Neulasta Supports First and Subsequent Cycle Administration Amgen ...
Starter Studies: Amgen Inc. Colgate-Palmolive Company
The Business Amgen Inc. is the world largest biotechnology company. It uses cellular and molecular biology, and medicinal chemistry, to discover, develop ...

Home Contact Resources Exchange Links ebay